Table 1

Patient characteristics, for all patients and for the subgroups of patients with DES excluding BVS, BMS and BVS

TotalDES excluding BVSBMSBVS
Number (N)243 581143 76598 3761440
Age (median (IQR))71 (62–77)70 (61–76)72 (65–78)64 (55–73)
Female patients (%)32.2331.5233.3128.47
Diagnoses at the index hospital stay (%)*
  Cardiovascular diseases
   Prior MI9.6010.348.557.50
   Stroke0.480.400.590.28
   TIA0.270.210.350.14
   Intracerebral bleeding0.040.030.060.00
   Congestive heart failure26.6925.4528.5325.21
   NYHA stage >122.0721.0223.6221.67
   Coronary two-vessel disease31.5431.6331.3932.15
   Coronary three-vessel disease37.6340.3633.7330.49
   Left main CAD3.774.682.471.46
   Shock0.550.490.640.14
   Arterial hypertension78.6379.5277.3477.92
   Cardiac arrhythmia25.3020.4832.4417.29
   Valvular disease10.118.7512.147.43
   Peripheral vascular disorders11.5611.2512.068.06
  Other concomitant diseases
   Diabetes mellitus33.5135.2231.0728.75
   COPD9.558.7610.719.31
   CKD19.4818.7020.7312.15
   ESRD3.923.913.972.26
   Hypothyroidism7.227.546.719.44
   Obesity (BMI ≥30 kg/m²)12.0012.0311.9313.96
Interventions at index hospital stay (%)
 PCI > 1 coronary artery†13.5218.456.3212.57
  Pacemaker1.201.041.450.63
  ICD implantation0.790.700.930.28
  Dialysis1.751.592.000.69
  • *Other comorbidities according to Elixhauser et al with a frequency <5% are not shown (pulmonary circulation disorders, liver disease, blood loss anaemia, deficiency anaemia, peptic ulcer disease excluding bleeding, coagulopathy, weight loss, solid tumour without metastasis, metastatic cancer, lymphoma, rheumatoid arthritis/collagen, paralysis, other neurological disorders, alcohol abuse, drug abuse, psychoses, depression, AIDS/HIV).

  • †At least two stents in one or more coronary arteries during index hospitalisation.

  • BMS, bare metal stent; BVS, bio-resorbable vascular scaffold; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; DES, drug-eluting stent; ESRD, end-stage renal disease; ICD, implantable cardioverter defibrillator; MI, myocardial infarction; NYHA, New York Heart Association; TIA, transient ischaemic attack.